Camurus AB (CHIX:CAMXS) Cyclically Adjusted FCF per Share: kr-0.37 (As of Mar. 2026)


CHIX:CAMXS Camurus AB CHIX:CAMXS
86 GF Score
Price kr564.00
GF Value kr694.35
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Camurus AB Cyclically Adjusted FCF per Share?

Camurus AB CHIX:CAMXS 86 Cyclically Adjusted FCF per Share is kr-0.37 as of Mar. 2026. GuruFocus rates CHIX:CAMXS with a GF Score™ of 86/100 and a GF Value™ of kr694.35 (Modestly Undervalued). The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Camurus AB's adjusted free cash flow per share for the three months ended in Mar. 2026 was kr2.051. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is kr-0.37 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-07-13), Camurus AB's current stock price is kr564.00. Camurus AB's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was kr-0.37. Camurus AB's Cyclically Adjusted Price-to-FCF of today is .


Camurus AB  (CHIX:CAMXs) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Camurus AB Cyclically Adjusted FCF per Share Related Terms


Camurus AB Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Camurus AB's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Camurus AB Cyclically Adjusted FCF per Share Chart

Camurus AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 -1.75 -2.32 -1.04

Camurus AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.11 -1.54 -1.28 -1.04 -0.37

CHIX:CAMXS vs VRTX, REGN, ALNY: Cyclically Adjusted FCF per Share Comparison

For the Biotechnology subindustry, Camurus AB's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Camurus AB Cyclically Adjusted Price-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Camurus AB's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Camurus AB's Cyclically Adjusted Price-to-FCF falls into.


CHIX:CAMXS
86GF Score
Camurus AB CHIX:CAMXS
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Camurus AB Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Camurus AB's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=2.051/133.5600*133.5600
=2.051

Current CPI (Mar. 2026) = 133.5600.

Camurus AB Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 -0.642 101.019 -0.849
201609 -0.770 101.138 -1.017
201612 -0.252 102.022 -0.330
201703 -1.088 102.022 -1.424
201706 -1.473 102.752 -1.915
201709 -1.050 103.279 -1.358
201712 -1.327 103.793 -1.708
201803 -1.244 103.962 -1.598
201806 -1.915 104.875 -2.439
201809 -1.877 105.679 -2.372
201812 -1.571 105.912 -1.981
201903 -2.193 105.886 -2.766
201906 -2.420 106.742 -3.028
201909 -1.785 107.214 -2.224
201912 -2.275 107.766 -2.820
202003 -1.239 106.563 -1.553
202006 -1.249 107.498 -1.552
202009 -0.622 107.635 -0.772
202012 -1.334 108.296 -1.645
202103 -1.097 108.360 -1.352
202106 -0.761 108.928 -0.933
202109 -0.076 110.338 -0.092
202112 -0.717 112.486 -0.851
202203 -0.154 114.825 -0.179
202206 0.165 118.384 0.186
202209 0.934 122.296 1.020
202212 0.778 126.365 0.822
202303 0.389 127.042 0.409
202306 1.085 129.407 1.120
202309 8.424 130.224 8.640
202312 0.481 131.912 0.487
202403 0.587 132.205 0.593
202406 1.626 132.716 1.636
202409 2.399 132.304 2.422
202412 1.391 132.987 1.397
202503 0.729 132.825 0.733
202506 5.809 133.699 5.803
202509 2.144 133.480 2.145
202512 3.476 133.390 3.480
202603 2.051 133.560 2.051

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of kr-0.37 mean?
Camurus AB (CHIX:CAMXS) has a Cyclically Adjusted FCF per Share of kr-0.37 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Camurus AB and its competitors.
Is Camurus AB's Cyclically Adjusted FCF per Share too high?
Camurus AB's current Cyclically Adjusted FCF per Share is kr-0.37. Overall, Camurus AB has a GF Score™ of 86/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Camurus AB's Cyclically Adjusted FCF per Share compare to VRTX and REGN?
Camurus AB's Cyclically Adjusted FCF per Share of kr-0.37 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Biotechnology company?
A good Cyclically Adjusted FCF per Share depends on the Biotechnology industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Camurus AB and its competitors. Camurus AB's current Cyclically Adjusted FCF per Share is kr-0.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Camurus AB stock overvalued right now?
Based on GuruFocus' analysis, Camurus AB (CHIX:CAMXS) is currently considered Modestly Undervalued. The stock's GF Value™ is kr694.35, compared to a current price of kr564.00 — trading 18.8% below its estimated fair value. The current Cyclically Adjusted FCF per Share is kr-0.37. Camurus AB's overall GF Score™ is 86/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Camurus AB (CHIX:CAMXS), the current Cyclically Adjusted FCF per Share is kr-0.37 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Camurus AB (CHIX:CAMXS) Overvalued in 2026?

Based on GuruFocus' analysis, Camurus AB stock appears to be undervalued. The current stock price of kr564.00 is trading 18.8% below its estimated GF Value™ of kr694.35. GuruFocus considers Camurus AB to be Modestly Undervalued.

Key valuation signals for CHIX:CAMXS:

  • Cyclically Adjusted FCF per Share: kr-0.37
  • GF Value™: kr694.35 vs. price of kr564.00 (18.8% below fair value)
  • GF Score™: 86/100 with 1 warning sign

No single metric tells the full story. See the CHIX:CAMXS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Camurus AB Business Description

Address Rydbergs torg 4, Lund, SWE, SE-224 84
Camurus AB is a science-led biopharmaceutical company focused on developing and commercializing long-acting medicines for the treatment of severe and chronic diseases. It has two approved products, including treatments for opioid dependence, and a development pipeline supported by its FluidCrystal technology. Its clinical pipeline includes product candidates for conditions such as pain, cancer, endocrine, and metabolic diseases, developed in-house and in collaboration with international pharmaceutical companies. Its pipeline programs include CAM2029 for acromegaly, gastroenteropancreatic neuroendocrine tumors, and polycystic liver disease; CAM2038 for chronic pain; CAM4072 for genetic obesity disorders; CAM2043 for Raynaud's phenomenon; CAM4071 for endocrine disorders, among others.
86GF Score

Get the complete analysis for CHIX:CAMXS

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr564.00
Price
kr694.35
GF Value